{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T09:23:50Z","timestamp":1707211430099},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2011,3,24]],"date-time":"2011-03-24T00:00:00Z","timestamp":1300924800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Radiologe"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1007\/s00117-010-2095-5","type":"journal-article","created":{"date-parts":[[2011,3,22]],"date-time":"2011-03-22T17:19:28Z","timestamp":1300814368000},"page":"273-277","source":"Crossref","is-referenced-by-count":3,"title":["Klinische und bildgebende Diagnostik bei Morbus Parkinson und Multisystematrophie"],"prefix":"10.1007","volume":"51","author":[{"given":"K. I.","family":"Schmidt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Spiegel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Reith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,3,24]]},"reference":[{"key":"2095_CR1","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s10072-003-0103-5","volume":"24","author":"Antonini","year":"2003","unstructured":"Antonini A, Benti R, De Notaris R et al (2003) 123I-Ioflupane\/SPECT binding to striatal dopamine transporter (DAT) uptake in patients with Parkinson\u2019s disease, multiple system atrophy, and progressive supranuclear palsy. Neurol Sci 24:149\u2013150","journal-title":"Neurol Sci"},{"key":"2095_CR2","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/1531-8257(200005)15:3<503::AID-MDS1013>3.0.CO;2-V","volume":"15","author":"Benamer","year":"2000","unstructured":"Benamer TS, Patterson J, Grosset DG et al (2000) Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: the [123I]-FP-CIT study group. Mov Disord 15:503-510","journal-title":"Mov Disord"},{"key":"2095_CR3","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/mds.10482","volume":"18","author":"Benamer","year":"2003","unstructured":"Benamer HT, Oertel WH, Patterson J et al (2003) Prospective study of presynaptic dopaminergic imaging in patients with mild parkinsonism and tremor disorders: part 1. Baseline and 3-month observations. Mov Disord 18:977\u2013984","journal-title":"Mov Disord"},{"key":"2095_CR4","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0022-510X(73)90175-5","volume":"20","author":"Bernheimer","year":"1973","unstructured":"Bernheimer H, Birkmayer W, Hornykiewicz O et al (1973) Brain dopamine and the syndromes of Parkinson and Huntington. J Neurol Sci 20:415\u2013455","journal-title":"J Neurol Sci"},{"key":"2095_CR5","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s002590050190","volume":"25","author":"Booij","year":"1998","unstructured":"Booij J, Busemann Sokole E et al (1998) Human biodistribution and dosimetry of [123I]FP-CIT: a potent radioligand for imaging of dopamine transporters. Eur J Nucl Med Mol Imaging 25:24\u201330","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2095_CR6","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00441-004-0956-9","volume":"318","author":"Braak","year":"2004","unstructured":"Braak H, Ghebremedhin E, R\u00fcb U et al (2004) Stages in the development of Parkinson\u2019s disease-related pathology. Cell Tissue Res 318:121\u2013134","journal-title":"Cell Tissue Res"},{"key":"2095_CR7","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/BF02292766","volume":"11","author":"Braune","year":"2001","unstructured":"Braune S (2001) The role of cardiac metaiodobenzylguanidine uptake in the differential diagnosis of parkinsonian syndromes. Clin Auton Res 11:351\u2013355","journal-title":"Clin Auton Res"},{"key":"2095_CR8","unstructured":"Deuschl G, Krack P (1999) Morbus Parkinson. In: Hopf HC, Deuschl G, Diener HC, Reichmann H (Hrsg) Neurologie in Praxis und Klinik, Bd 2. Thieme, Stuttgart New York, S 49\u201369"},{"key":"2095_CR9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0022-510X(00)00279-3","volume":"175","author":"Druschky","year":"2000","unstructured":"Druschky A, Hilz MJ, Platsch G et al (2000) Differentiation of Parkinson\u2019s disease and multiple system atrophy in early disease stages by means of I-123-MIBG-SPECT. J Neurol Sci 175:3\u201312","journal-title":"J Neurol Sci"},{"key":"2095_CR10","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1136\/jnnp.2004.045237","volume":"76","author":"Eerola","year":"2005","unstructured":"Eerola J, Tienari PJ, Kaakkola S et al (2005) How useful is [123I]beta-CIT SPECT in clinical practice? J Neurol Neurosurg Psychiatry 76:1211\u20131216","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2095_CR11","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/00006231-200505000-00005","volume":"26","author":"Filippi","year":"2005","unstructured":"Filippi L, Manni C, Pierantozzi M et al (2005) 123I-FP-CIT semi-quantitative SPECT detects preclinical bilateral dopaminergic deficit in early Parkinson\u2019s disease with unilateral symptoms. Nucl Med Commun 26:421\u2013426","journal-title":"Nucl Med Commun"},{"key":"2095_CR12","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","volume":"55","author":"Hughes","year":"1992","unstructured":"Hughes A, Daniel SE, Kilford L et al (1992) Accuracy of clinical diagnosis of idiopathic Parkinson\u2018s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181\u2013184","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2095_CR13","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1212\/WNL.43.8.1630","volume":"43","author":"Hughes","year":"1993","unstructured":"Hughes A, Ben-Shlomo Y, Daniel SE et al (1993) What feasures improve the accuracy of clinical diagnosis in Parkinson\u2019s disease: a clinicopathologic study. Neurology 43:1629\u20131630","journal-title":"Neurology"},{"key":"2095_CR14","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1212\/WNL.52.6.1206","volume":"52","author":"Ichise","year":"1999","unstructured":"Ichise M, Kim YJ, Ballinger JR et al (1999) SPECT imaging of pre- and postsynaptic dopaminergic alterations in L-dopa-untreated PD. Neurology 52:1206\u20131214","journal-title":"Neurology"},{"key":"2095_CR15","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/1531-8257(199905)14:3<436::AID-MDS1008>3.0.CO;2-J","volume":"14","author":"Innis","year":"1999","unstructured":"Innis RB, Marek KL, Sheff K et al (1999) Effect of treatment with L-dopa\/carbidopa or L-selegiline on striatal dopamine transporter SPECT imaging with [123I]beta-CIT. Mov Disord 14:436\u2013442","journal-title":"Mov Disord"},{"key":"2095_CR16","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/BF02262730","volume":"18","author":"Khafagi","year":"1991","unstructured":"Khafagi FA, Shapiro B, Fischer M et al (1991) Phaeochromocytoma and functioning paraganglioma in childhood and adolescence: role of iodine 131 metaiodobenzylguanidine. Eur J Nucl Med Mol Imaging 18:191\u2013198","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2095_CR17","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1159\/000008124","volume":"43","author":"Kim","year":"2000","unstructured":"Kim GM, Kim SE, Lee WY (2000) Preclinical impairment of the striatal dopamine transporter system in sporadic olivopontocerebellar atrophy: studied with [123I] \u00df-CIT and SPECT. Eur Neurol 43:23\u201329","journal-title":"Eur Neurol"},{"key":"2095_CR18","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/mds.10042","volume":"17","author":"Kim","year":"2002","unstructured":"Kim YJ, Ichise M, Ballinger JR et al (2002) Combination of dopamine transporter and D2 receptor SPECT in the diagnostic evaluation of PD, MSA, and PSP. Mov Disord 17:303\u2013312","journal-title":"Mov Disord"},{"key":"2095_CR19","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1002\/mds.21614","volume":"22","author":"K\u00f6llensperger","year":"2007","unstructured":"K\u00f6llensperger M, Seppi K, Liener C et al (2007) Diffusion weighted imaging best discriminates PD from MSA-P: a comparison with tilt table testing and heart MIBG scintigraphy. Mov Disord 22:1771\u20131776","journal-title":"Mov Disord"},{"key":"2095_CR20","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1002\/mds.21083","volume":"21","author":"Lee","year":"2006","unstructured":"Lee PH, Yeo SH, Kim HJ, Youm HY (2006) Correlation between cardiac 123I-MIBG and odor identification in patients with Parkinson\u2019s disease and multiple system atrophy. Mov Disord 21:1975\u20131977","journal-title":"Mov Disord"},{"key":"2095_CR21","first-page":"1352","volume":"38","author":"Leung","year":"1997","unstructured":"Leung A, Shapiro B, Hattner R et al (1997) Specificity of radioiodinated MIBG for neural crest tumors in childhood. J Nucl Med 38:1352\u20131357","journal-title":"J Nucl Med"},{"key":"2095_CR22","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1001\/archneur.1997.00550200007003","volume":"54","author":"Litvan","year":"1997","unstructured":"Litvan I, Goetz CG, Jankovic J et al (1997) What is the accuracy of the clinical diagnosis of multiple system atrophy? A clinicopathologic study. Arch Neurol 54:937\u2013944","journal-title":"Arch Neurol"},{"key":"2095_CR23","first-page":"220","volume":"35","author":"Lumbroso","year":"1991","unstructured":"Lumbroso J, Hartmann O, Schlumberger M (1991) Therapeutic use of [131I]-metaiodo-benzylguanidine in neuroblastoma: a phase II study in 26 patients. \u201eSoci\u00e9t\u00e9 Francaise d\u2019Oncologie Pediatrique\u201c and Nuclear Medicine Co-investigators. J Nucl Biol Med 35:220\u2013223","journal-title":"J Nucl Biol Med"},{"key":"2095_CR24","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/S0959-8049(99)00114-8","volume":"35","author":"Mairs","year":"1999","unstructured":"Mairs R (1999) Neuroblastoma therapy using radiolabelled [131I] meta-iodobenzylguanidine ([131I] MIBG) in combination with other agents. Eur J Cancer 35:1171\u20131173","journal-title":"Eur J Cancer"},{"key":"2095_CR25","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s12149-008-0156-x","volume":"22","author":"Nagamachi","year":"2008","unstructured":"Nagamachi S, Wakamatsu H, Kiyohara S et al (2008) Usefulness of rCBF analysis in diagnosing Parkinson\u2019s disease: supplemental role with myocardial MIBG scintigraphy. Ann Nucl Med 22:557\u2013564","journal-title":"Ann Nucl Med"},{"key":"2095_CR26","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1136\/jnnp.2004.037028","volume":"76","author":"Nagayama","year":"2005","unstructured":"Nagayama H, Hamamoto M, Ueda M et al (2005) Reliability of MIBG myocardial scintigraphy in the diagnosis of Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 76:249\u2013251","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2095_CR27","first-page":"672","volume":"24","author":"Nakajo","year":"1983","unstructured":"Nakajo M, Shapiro B, Copp J et al (1983) The normal and abnormal distribution of the adrenomedullary imaging agent m-[I-131]iodo-benzyl-guanidine (I-131 MIBG) in man: evaluation by scintigraphy. J Nucl Med 24:672\u2013682","journal-title":"J Nucl Med"},{"key":"2095_CR28","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1111\/j.1440-1827.2004.01680.x","volume":"54","author":"Okada","year":"2004","unstructured":"Okada Y, Ito Y, Aida J et al (2004) Lewy bodies in the sinoatrial nodal ganglion: clinicopathological studies. Pathol Int 54:682\u2013687","journal-title":"Pathol Int"},{"key":"2095_CR29","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1136\/jnnp.67.2.189","volume":"67","author":"Orimo","year":"1999","unstructured":"Orimo S, Ozawa E, Nakade S et al (1999) (123)I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 67:189\u2013194","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2095_CR30","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1750-3639.2006.00032.x","volume":"17","author":"Orimo","year":"2007","unstructured":"Orimo S, Takahashi A, Uchihara T et al (2007) Degeneration of cardiac sympathetic nerve begins in the early disease process of Parkinson\u2019s disease. Brain Pathol 17:24\u201330","journal-title":"Brain Pathol"},{"key":"2095_CR31","doi-asserted-by":"crossref","first-page":"11","DOI":"10.5692\/clinicalneurol.48.11","volume":"48","author":"Orimo","year":"2008","unstructured":"Orimo S (2008) Clinical and pathological study on early diagnosis of Parkinson\u2019s disease and dementia with Lewy bodies. Rinsho Shinkeigaku 48:11\u201324","journal-title":"Rinsho Shinkeigaku"},{"key":"2095_CR32","first-page":"78","volume":"10","author":"Osborn","year":"2010","unstructured":"Osborn AG, Salzman KL, Barkovich AJ (2010) Diagnostic imaging. Brain 10:78\u201385","journal-title":"Brain"},{"key":"2095_CR33","unstructured":"Parkinson J (1817) An essay on the shaking palsy. London"},{"key":"2095_CR34","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1002\/1531-8257(200011)15:6<1158::AID-MDS1015>3.0.CO;2-0","volume":"15","author":"Pirker","year":"2000","unstructured":"Pirker W, Asenbaum S, Bencsits G et al (2000) [123I]beta-CIT SPECT in multiple system atrophy, progressive supranuclear palsy, and corticobasal degeneration. Mov Disord 15:1158\u20131167","journal-title":"Mov Disord"},{"key":"2095_CR35","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s00702-004-0208-x","volume":"112","author":"Plotkin","year":"2005","unstructured":"Plotkin M, Amthauer H, Klaffke S et al (2005) Combined 123I-FP-CIT and 123I-IBZM SPECT for the diagnosis of parkinsonian syndromes: study on 72 patients. J Neural Transm 112:677\u2013692","journal-title":"J Neural Transm"},{"key":"2095_CR36","unstructured":"Poewe W, Wenning GK, Gerlach M et al (1999) Nicht-idiopathische Parkinson-Syndrome. In: Hopf HC, Deuschl G, Diener HC, Reichmann H (Hrsg) Neurologie in Praxis und Klinik, Bd 2. Thieme, Stuttgart New York, S 69\u201378"},{"key":"2095_CR37","unstructured":"Reichmann H (2008) Neurodegenerative Erkrankungen. UNI-MED, Bremen"},{"key":"2095_CR38","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1468-1331.2008.02372.x","volume":"16","author":"Sawada","year":"2009","unstructured":"Sawada H, Oeda T, Yamamoto K et al (2009) Diagnostic accuracy of cardiac metaiodobenzylguanidine scintigraphy in Parkinson\u2019s disease. Eur J Neurol 16:174\u2013182","journal-title":"Eur J Neurol"},{"key":"2095_CR39","first-page":"1500","volume":"39","author":"Seibyl","year":"1998","unstructured":"Seibyl JP, Marek K, Sheff K et al (1998) Iodine-123-beta-CIT and iodine-123-FPCIT SPECT measurement of dopamine transporters in healthy subjects and Parkinson\u2019s patients. J Nucl Med 39:1500\u20131508","journal-title":"J Nucl Med"},{"key":"2095_CR40","first-page":"576","volume":"26","author":"Shapiro","year":"1985","unstructured":"Shapiro B, Copp JE, Sisson JC et al (1985) Iodine-131 metaiodobenzylguanidine for the locating of suspected pheochromocytoma: experience in 400 cases. J Nucl Med 26:576\u2013585","journal-title":"J Nucl Med"},{"key":"2095_CR41","first-page":"217","volume":"43","author":"Sisson","year":"1999","unstructured":"Sisson J, Shulkin B (1999) Nuclear medicine imaging of pheochromocytoma and neuroblastoma. Q J Nucl Med 43:217\u2013223","journal-title":"Q J Nucl Med"},{"key":"2095_CR42","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1093\/brain\/awl042","volume":"129","author":"Spiegel","year":"2006","unstructured":"Spiegel J, Hellwig D, M\u00f6llers MO et al (2006) Transcranial sonography and [123I]FP-CIT SPECT disclose complementary aspects of Parkinson\u2019s disease. Brain 129:1188\u20131193","journal-title":"Brain"},{"key":"2095_CR43","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00702-006-0518-2","volume":"114","author":"Spiegel","year":"2007","unstructured":"Spiegel J, Hellwig D, Samnick S et al (2007) Striatal FP-CIT uptake differs in the subtypes of early Parkinson\u2019s disease. J Neural Transm 114:331\u2013335","journal-title":"J Neural Transm"},{"key":"2095_CR44","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1002\/mds.21499","volume":"22","author":"Spiegel","year":"2007","unstructured":"Spiegel J, Hellwig D, Farmakis G et al (2007) Myocardial sympathetic degeneration correlates with clinical phenotype of Parkinson\u2019s disease. Mov Disord 22:1004\u20131008","journal-title":"Mov Disord"},{"key":"2095_CR45","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1007\/s002590050544","volume":"27","author":"Taki","year":"2000","unstructured":"Taki J, Nakajima K, Hwang EH et al (2000) Peripheral sympathetic dysfunction in patients with Parkinson\u2019s disease without autonomic failure is heart selective and disease specific. Eur J Nucl Med Mol Imaging 27:566\u2013573","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2095_CR46","first-page":"Parkinson","volume":"6","author":"Turner","year":"1968","unstructured":"Turner B (1968) Pathology of paralysis agitans. In: Vinken PJ, Bruyn GW (eds) Handbook of clinical neurology. Vol 6: Parkinson\u2019s disease. North-Holland Publishing Company, Amsterdam; Wiley & Sons, New York, pp 212\u2013217","journal-title":"Vol"},{"key":"2095_CR47","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1007\/s00259-004-1480-6","volume":"31","author":"Van","year":"2004","unstructured":"Van Laere K, Ceuninck L de, Dom R et al (2004) Dopamine transporter SPECT using fast kinetic ligands: 123I-FP-beta-CIT versus 99mTc-TRODAT-1. Eur J Nucl Med Mol Imaging 31:1119\u20131127","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2095_CR48","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1002\/mds.1256","volume":"16","author":"Varrone","year":"2001","unstructured":"Varrone A, Marek KL, Jennings D et al (2001) [(123)I]beta-CIT SPECT imaging demonstrates reduced density of striatal dopamine transporters in Parkinson\u2019s disease and multiple system atrophy. Mov Disord 16:1023\u20131032","journal-title":"Mov Disord"},{"key":"2095_CR49","first-page":"349","volume":"21","author":"Wieland","year":"1980","unstructured":"Wieland DM, Wu J, Brown LE et al (1980) Radiolabeled adrenergic neuron-blocking agents: adrenomedullary imaging with [131I] iodobenzylguanidine. J Nucl Med 21:349\u2013353","journal-title":"J Nucl Med"},{"key":"2095_CR50","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0022-510X(97)00278-5","volume":"155","author":"Yoshita","year":"1998","unstructured":"Yoshita M (1998) Differentiation of idiopathic Parkinson\u2019s disease from striatonigral degeneration and progressive supranuclear palsy using iodine-123 meta-iodobenzylguanidine myocardial scintigraphy. J Neurol Sci 155:60\u201367","journal-title":"J Neurol Sci"}],"container-title":["Der Radiologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00117-010-2095-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00117-010-2095-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00117-010-2095-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T05:24:22Z","timestamp":1558589062000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00117-010-2095-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,24]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["2095"],"URL":"https:\/\/doi.org\/10.1007\/s00117-010-2095-5","relation":{},"ISSN":["0033-832X","1432-2102"],"issn-type":[{"value":"0033-832X","type":"print"},{"value":"1432-2102","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,24]]}}}